M
Maria Toumpourleka
Researcher at Aristotle University of Thessaloniki
Publications - 32
Citations - 225
Maria Toumpourleka is an academic researcher from Aristotle University of Thessaloniki. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 5, co-authored 19 publications receiving 84 citations.
Papers
More filters
Journal ArticleDOI
Macrovascular Complications of Type 2 Diabetes Mellitus.
Margus Viigimaa,Alexandros Sachinidis,Maria Toumpourleka,Konstantinos Koutsampasopoulos,Signe Alliksoo,Tiina Titma +5 more
TL;DR: T2DM causes a variety of macrovascular complications through different pathogenetic pathways that include hyperglycaemia and insulin resistance, which need more clinical studies in order to identify the pure effect of T2DM.
Journal ArticleDOI
Breast Radiotherapy and Early Adverse Cardiac Effects. The Role of Serum Biomarkers and Strain Echocardiography.
Areti Gkantaifi,Christodoulos Papadopoulos,Despoina Spyropoulou,Maria Toumpourleka,George Iliadis,Dimitrios Kardamakis,Michail Nikolaou,Nikolaos Tsoukalas,George Kyrgias,Maria Tolia +9 more
TL;DR: The impact of certain cardiac biomarkers and strain echocardiographic imaging on the detection of early cardiac dysfunction is clarified to minimize the side-effects of therapeutic modalities in the clinical setting.
Journal ArticleDOI
Colchicine as a Potential Therapeutic Agent Against Cardiovascular Complications of COVID-19: an Exploratory Review.
Christodoulos Papadopoulos,Dimitrios Patoulias,Eleftherios Teperikidis,Dimitrios Mouselimis,Anastasios Tsarouchas,Maria Toumpourleka,Aristi Boulmpou,Constantinos Bakogiannis,Michael Doumas,Michael Doumas,Vassilios Vassilikos +10 more
TL;DR: According to this research, colchicine may be an agent of interest in the treatment of COVID-19 via its anti-inflammatory properties, however, there are potential drug interactions with cytochrome P450 3A4 inhibitors resulting in acute col chicine toxicities.
Journal ArticleDOI
Lung Ultrasound-Guided Dry-Weight Reduction in Hemodialysis Patients Does Not Affect Short-Term Blood Pressure Variability.
Charalampos Loutradis,Pantelis Sarafidis,Marieta Theodorakopoulou,Robert Ekart,Maria Eleni Alexandrou,Nikolaos Pyrgidis,Elena Angeloudi,Georgios Tzanis,Maria Toumpourleka,Dorothea Papadopoulou,Francesca Mallamaci,Carmine Zoccali,Aikaterini Papagianni +12 more
TL;DR: This study is the first to evaluate the effects of a nonpharmacological intervention on short-term BPV in hemodialysis, showing no effect of dry-weight reduction on BPV, despite BP decrease.
Journal ArticleDOI
Epidemiology and management of chronic thromboembolic pulmonary hypertension: experience from two expert centers
Maria Anna Bazmpani,Alexandra Arvanitaki,Maria Toumpourleka,Georgia Pitsiou,Evangelia Panagiotidou,Sophia-Anastasia Mouratoglou,Georgios Sianos,Stavros Hadjimiltiades,Antonios A. Pitsis,Eckhard Mayer,Ioannis Stanopoulos,Haralambos Karvounis,George Giannakoulas +12 more
TL;DR: The percentage of patients who underwent surgical treatment is lower but approaches the reported rates in large registries, and the need for establishing a designated PEA center in Greece is emphasized.